Literature DB >> 17166306

Neuropsychiatric predictors of return to work in HIV/AIDS.

Wilfred G van Gorp1, Judith G Rabkin, Stephen J Ferrando, Jim Mintz, Elizabeth Ryan, Thomas Borkowski, Martin McElhiney.   

Abstract

This study followed 118 HIV+ individuals who had taken steps to return to work to determine facilitators or barriers in returning to work. Over the two-year study period, 52% of the participants obtained employment. Memory function served as the most potent predictor of obtaining employment. Persons who were younger, did not have a diagnosis of AIDS and who had shorter periods of unemployment prior to entering the study also had better chances of finding employment during the study. After finding employment, participants reported lower levels of depression as well, an apparent result of their obtaining employment. These findings indicate that memory is a key neuropsychiatric variable that is perhaps most relevant to HIV+ persons' quest to return to work.

Entities:  

Mesh:

Year:  2007        PMID: 17166306     DOI: 10.1017/S1355617707070117

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  38 in total

1.  Is prospective memory a dissociable cognitive function in HIV infection?

Authors:  Saurabh Gupta; Steven Paul Woods; Erica Weber; Matthew S Dawson; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2010-04-27       Impact factor: 2.475

2.  Self-generation enhances verbal recall in individuals infected with HIV.

Authors:  Erica Weber; Steven Paul Woods; Emily Kellogg; Igor Grant; Michael R Basso
Journal:  J Int Neuropsychol Soc       Date:  2011-10-12       Impact factor: 2.892

3.  The role of depression in work-related outcomes of HIV treatment in Uganda.

Authors:  Glenn J Wagner; Bonnie Ghosh-Dastidar; Mary Slaughter; Dickens Akena; Noeline Nakasujja; Elialilia Okello; Seggane Musisi
Journal:  Int J Behav Med       Date:  2014-12

4.  Longitudinal trajectories of neurocognitive test performance among individuals with perinatal HIV-infection and -exposure: adolescence through young adulthood.

Authors:  Reuben N Robbins; R Zimmerman; R Korich; J Raymond; C Dolezal; C J Choi; C S Leu; N Nguyen; K Malee; A Wiznia; E J Abrams; C A Mellins
Journal:  AIDS Care       Date:  2019-06-07

Review 5.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

6.  Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study.

Authors:  April D Thames; Alyssa Arentoft; Monica Rivera-Mindt; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2012-12-14       Impact factor: 2.475

Review 7.  Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.

Authors:  Erica Weber; Kaitlin Blackstone; Steven Paul Woods
Journal:  Neuropsychol Rev       Date:  2013-02-16       Impact factor: 7.444

8.  Labor force participation and health-related quality of life in HIV-positive men who have sex with men: the Multicenter AIDS Cohort Study.

Authors:  Sergio Rueda; Janet Raboud; Michael Plankey; David Ostrow; Cameron Mustard; Sean B Rourke; Lisa P Jacobson; Tsegaye Bekele; Ahmed Bayoumi; John Lavis; Roger Detels; Anthony J Silvestre
Journal:  AIDS Behav       Date:  2012-11

9.  Effect of Retrieval Practice on Short-Term and Long-Term Retention in HIV+ Individuals.

Authors:  Gunes Avci; Steven P Woods; Marizela Verduzco; David P Sheppard; James F Sumowski; Nancy D Chiaravalloti; John DeLuca
Journal:  J Int Neuropsychol Soc       Date:  2017-01-09       Impact factor: 2.892

10.  An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection.

Authors:  Pariya L Fazeli; Steven Paul Woods; Robert K Heaton; Anya Umlauf; Ben Gouaux; Debra Rosario; Raeanne C Moore; Igor Grant; David J Moore
Journal:  J Neurovirol       Date:  2014-02-20       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.